4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-25-000003
Chief Executive Officer gave up 11,581 shares (to pay taxes)
- Chief Executive Officer acquired 24,484 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shea Jacqueline Elizabeth · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Exercise or conversion : show line 1 in the form | +5,852 | 39,499 | D | ||
| 2025-02-26 | Shares withheld for taxes : show line 2 in the form | −2,493 | $1.98 | $4,936 | 37,006 | D |
| 2025-02-26 | Exercise or conversion : show line 3 in the form | +18,632 | 55,638 | D | ||
| 2025-02-26 | Shares withheld for taxes : show line 4 in the form | −9,088 | $1.98 | $17,994 | 46,550 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-26 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −5,852 | 0 | D |
| 2025-02-26 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −18,632 | 37,263 | D |
| 2025-02-27 | Grant or award : show line 7 in the form Common Stock Option | +105,649 | 105,649 | D |
| 2025-02-27 | Grant or award : show line 8 in the form Restricted Stock Unit | +85,201 | 85,201 | D |
Loading xslF345X05/wk-form4_1740783933.xml…